
Gilead’s cell therapy business Kite cuts 7% of workforce
Gilead’s cell therapy subsidiary Kite Pharma is letting go of roughly 300 employees, or about 7% of the unit’s staff. “We are taking measures to further align our business for future growth, including streamlining some […]